Decentralized Testing and Centralized Reporting for Rapid Disease Surveillance
Deploy rapid, field-based molecular testing where it’s needed most for outbreak response and epidemiological studies with a palm-sized molecular lab.
Faster Detection. Smarter Public Health Decisions.
Timely infectious disease detection is crucial for public health response and outbreak containment. AlveoSense enables rapid, on-site molecular testing for emerging pathogens, providing health agencies and researchers with critical data in real-time. Decentralized testing helps improve disease surveillance, enhance response efforts, and protect communities.
If you are looking for support for any be.well® or Alveo Sense™ product, contact customer support here
Strengthening Public Health Initiatives with Point of Care Molecular Testing
Portable testing for field-based outbreak response.
30–60 minute results for rapid decision-making.
Cloud-based data sharing for integrated public health tracking.
Adaptable platform for multiple infectious disease targets.
Our growing network of partnerships is advancing product development on our open-source platform.
Propelling access to rapid, point-of-need molecular detection beyond healthcare to enable better outcomes across industries, regions, and communities.
